Using dashboards to verify coronavirus (COVID-19) vaccinations can reduce fatality rates in countries/regions: Development and usability study

Background: The new coronavirus disease 2019 (COVID-19) pandemic is raging worldwide. The administered vaccination has become a significant vehicle against the virus. Three hypotheses were made and required for validation: the number of vaccines administered is related to the country gross domestic product (GDP), vaccines can reduce the fatality rate (FR), and dashboards can present more meaningful information than traditionally static visualizations. Research data were downloaded from the GitHub website. The aims of this study are to verify that the number of vaccination uptakes is related to the country GDP, that vaccines can reduce FR, and that dashboards can provide more meaningful information than traditionally static visualizations. Methods: The COVID-19 cumulative number of confirmed cases (CNCCs) and deaths were downloaded from the GitHub website for countries/regions on November 6, 2021. Four variables between January 1, 2021, and November 6, 2021, were collected, including CNCCs and deaths, GDP per capita, and vaccine doses administered per 100 people (VD100) in countries/regions. We applied the Kano model, forest plot, and choropleth map to demonstrate and verify the 3 hypotheses using correlation coefficients (CC) between vaccination and FRs. Dashboards used to display the vaccination effects were on Google Maps. Results: We observed that the higher the GDP, the more vaccines are administered (Association = 0.68, t = 13.14, P < .001) in countries, the FR can be reduced by administering vaccinations that are proven except for the 4 groups of Asia, Low income, Lower middle income, and South America, as well as the application (app) with dashboard-type choropleth map can be used to show the comparison of vaccination rates for countries/regions using line charts. Conclusion: This research uses the Kano map, forest plot, and choropleth map to verify the 3 hypotheses and provides insights into the vaccination effect against the FR for relevant epidemic studies in the future.

[1]  I. Rudan,et al.  Research priorities to reduce the impact of COVID-19 in low- and middle-income countries , 2022, Journal of global health.

[2]  D. Ferrante,et al.  Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country , 2021, JAMA network open.

[3]  A. Sarker,et al.  COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions , 2021, Frontiers in Public Health.

[4]  T. Chien,et al.  Predicting the number of article citations on the topic of pemphigus vulgaris with the 100 top-cited articles since 2011 , 2021, Medicine.

[5]  Kasturi Dewi Varathan,et al.  Investigating transportation research based on social media analysis: a systematic mapping review , 2021, Scientometrics.

[6]  M. Haghani,et al.  Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature , 2021, Scientometrics.

[7]  M. Yousefi,et al.  SARS-CoV-2: Unique Challenges of the Virus and Vaccines , 2021, Immunological investigations.

[8]  S. S. Sheinfeld Gorin,et al.  Global Trends and Correlates of COVID-19 Vaccination Hesitancy: Findings from the iCARE Study , 2021, Vaccines.

[9]  Hsiu-Hsi Chen,et al.  Economic evaluation for mass vaccination against COVID-19 , 2021, Journal of the Formosan Medical Association.

[10]  X. Xiong,et al.  Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination , 2021, Frontiers in Medicine.

[11]  N. Javed,et al.  COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation , 2021, Infectious disease reports.

[12]  T. Chien,et al.  An online time-to-event dashboard comparing the effective control of COVID-19 among continents using the inflection point on an ogive curve , 2021, Medicine.

[13]  A. Gawande,et al.  Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic. , 2021, The New England journal of medicine.

[14]  A. Gulbake,et al.  COVID-19 vaccines: rapid development, implications, challenges and future prospects , 2021, Human Cell.

[15]  M. Hernán,et al.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.

[16]  T. Chien,et al.  The use of forest plot to identify article similarity and differences in characteristics between journals using medical subject headings terms , 2021, Medicine.

[17]  T. Chien,et al.  Using the IPcase Index with Inflection Points and the Corresponding Case Numbers to Identify the Impact Hit by COVID-19 in China: An Observation Study , 2021, International journal of environmental research and public health.

[18]  M. Fleurbaey,et al.  Just allocation of COVID-19 vaccines , 2021, BMJ Global Health.

[19]  J. Mascola,et al.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.

[20]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.

[21]  M. Eisenhut,et al.  How to control the coronavirus without shutting down country: Lessons from the flattened curve of South Korea. , 2020, Journal of medical Internet research.

[22]  Jianbing Hu,et al.  Analysis of second outbreak of COVID-19 after relaxation of control measures in India , 2020, Nonlinear Dynamics.

[23]  Ariel Rosenfeld,et al.  Publication patterns’ changes due to the COVID-19 pandemic: a longitudinal and short-term scientometric analysis , 2020, Scientometrics.

[24]  J. Mascola,et al.  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.

[25]  T. Chien,et al.  Therapeutic Duplication in Taiwan Hospitals for Patients With High Blood Pressure, Sugar, and Lipids: Evaluation With a Mobile Health Mapping Tool , 2020, JMIR medical informatics.

[26]  M. Roser,et al.  Coronavirus Pandemic (COVID-19) , 2020 .

[27]  T. Chien,et al.  Using Kano diagrams to display the most cited article types, affiliated countries, authors and MeSH terms on spinal surgery in recent 12 years , 2020, European Journal of Medical Research.

[28]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[29]  Yan Zhao,et al.  A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) , 2020, Military Medical Research.

[30]  Hiroshi Nishiura,et al.  The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights , 2020, Journal of clinical medicine.

[31]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, bioRxiv.

[32]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[33]  T. Chien,et al.  Choropleth map legend design for visualizing the most influential areas in article citation disparities , 2019, Medicine.

[34]  T. Fenner,et al.  A novel bibliometric index with a simple geometric interpretation , 2018, PloS one.

[35]  J. Stephenson.  Explaining the forest plot in meta-analyses. , 2017, Journal of wound care.

[36]  M. Lal.  Middle East respiratory syndrome coronavirus (MERS-CoV) , 2016 .

[37]  P. Sedgwick.  How to read a forest plot in a meta-analysis , 2015, BMJ : British Medical Journal.

[38]  M. S. Patel,et al.  An introduction to meta-analysis. , 1989, Health Policy.

[39]  N. Kano,et al.  Attractive Quality and Must-Be Quality , 1984 .

[40]  F. Lord.  Applications of Item Response Theory To Practical Testing Problems , 1980 .

[41]  Frederic M. Lord,et al.  Practical Applications of Item Characteristic Curve Theory. , 1977 .

[42]  J. R. Scotti,et al.  Available From , 1973 .